Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease? - PubMed (original) (raw)

. 2019 Sep;30(6):612-616.

doi: 10.1080/09546634.2018.1527998. Epub 2018 Nov 19.

Affiliations

Free article

Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?

Rosanna Satta et al. J Dermatolog Treat. 2019 Sep.

Free article

Abstract

Background: Inflammatory bowel diseases (IBDs) are associated with extraintestinal manifestations including skin lesions. The intestinal microflora plays a key role in the development and course of IBD. Aim: To examine the efficacy of probiotics and the occurrence of skin lesions in patients with IBD. Methods: The occurrence of cutaneous lesions in IBD patients from Northern Sardinia was analyzed according to demographic, anthropometrics, clinical features, treatments, and probiotic use expressed as the ratio of disease duration under probiotic treatment and the total disease duration. Results: In 170 IBD patients (59.4% women; UC: 61.2%) at least one skin lesion was present (8.2%) at diagnosis and in 30.6% developed during the follow-up. Psoriasis, erythema nodosum, and pyoderma gangrenosum were the most frequent. An inverse trend was observed between probiotics use and skin lesions occurrence after adjusting for confounders, including conventional treatment for IBD. The risk of developing at least one skin lesion was 1.40 for probiotic use between 5-19% of disease duration and 0.3 for probiotic use > 50%. Body mass index, Crohn phenotype, marriage, and potency of IBD-treatment were significant predictors for developing skin lesions. Conclusion: These findings suggest that probiotics may be an additional tool in the treatment of IBD.

Keywords: Inflammatory bowel disease; cutaneous manifestations; probiotics.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

LinkOut - more resources